

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.80572615 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.30679959 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.30679959 |
| 4 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.19895047 |
| 5 | protein carboxylation (GO:0018214) | 4.19895047 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 4.16443490 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.16443490 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.14303602 |
| 9 | urea cycle (GO:0000050) | 4.10730228 |
| 10 | urea metabolic process (GO:0019627) | 4.10730228 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 4.06191984 |
| 12 | cysteine metabolic process (GO:0006534) | 4.01973762 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 4.00793025 |
| 14 | aromatic amino acid family catabolic process (GO:0009074) | 3.97238758 |
| 15 | complement activation, alternative pathway (GO:0006957) | 3.92396218 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.83257499 |
| 17 | negative regulation of cell killing (GO:0031342) | 3.81809177 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.81809177 |
| 19 | phospholipid homeostasis (GO:0055091) | 3.80599825 |
| 20 | regulation of cholesterol homeostasis (GO:2000188) | 3.80157843 |
| 21 | kynurenine metabolic process (GO:0070189) | 3.71763002 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.70719162 |
| 23 | plasma lipoprotein particle clearance (GO:0034381) | 3.70266618 |
| 24 | low-density lipoprotein particle clearance (GO:0034383) | 3.69970761 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 3.69537796 |
| 26 | regulation of protein activation cascade (GO:2000257) | 3.68461585 |
| 27 | tryptophan catabolic process (GO:0006569) | 3.65713954 |
| 28 | indole-containing compound catabolic process (GO:0042436) | 3.65713954 |
| 29 | indolalkylamine catabolic process (GO:0046218) | 3.65713954 |
| 30 | response to peptidoglycan (GO:0032494) | 3.64668184 |
| 31 | sulfur amino acid catabolic process (GO:0000098) | 3.62811105 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 3.57494302 |
| 33 | tryptophan metabolic process (GO:0006568) | 3.56284463 |
| 34 | phospholipid efflux (GO:0033700) | 3.52743167 |
| 35 | regulation of complement activation (GO:0030449) | 3.49417189 |
| 36 | regulation of cholesterol storage (GO:0010885) | 3.49009497 |
| 37 | regulation of fibrinolysis (GO:0051917) | 3.48756138 |
| 38 | positive thymic T cell selection (GO:0045059) | 3.43862443 |
| 39 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.41883749 |
| 40 | bile acid biosynthetic process (GO:0006699) | 3.41722309 |
| 41 | homocysteine metabolic process (GO:0050667) | 3.38761716 |
| 42 | glyoxylate metabolic process (GO:0046487) | 3.38525273 |
| 43 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.37879149 |
| 44 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.37879149 |
| 45 | modulation by symbiont of host immune response (GO:0052553) | 3.37879149 |
| 46 | positive regulation by symbiont of host defense response (GO:0052509) | 3.37879149 |
| 47 | modulation by symbiont of host defense response (GO:0052031) | 3.37879149 |
| 48 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.37879149 |
| 49 | detection of other organism (GO:0098543) | 3.35313014 |
| 50 | protein-lipid complex assembly (GO:0065005) | 3.35131217 |
| 51 | reverse cholesterol transport (GO:0043691) | 3.32867358 |
| 52 | plasma lipoprotein particle assembly (GO:0034377) | 3.30167417 |
| 53 | mannose metabolic process (GO:0006013) | 3.29059055 |
| 54 | regulation of gamma-delta T cell activation (GO:0046643) | 3.28798641 |
| 55 | detection of bacterium (GO:0016045) | 3.27302248 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.26711552 |
| 57 | serine family amino acid catabolic process (GO:0009071) | 3.26665244 |
| 58 | cholesterol efflux (GO:0033344) | 3.26296194 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 3.23245143 |
| 60 | negative regulation of sterol transport (GO:0032372) | 3.23245143 |
| 61 | lysine metabolic process (GO:0006553) | 3.19540804 |
| 62 | lysine catabolic process (GO:0006554) | 3.19540804 |
| 63 | neutrophil activation involved in immune response (GO:0002283) | 3.18647432 |
| 64 | protein localization to endosome (GO:0036010) | 3.18567213 |
| 65 | regulation of leukocyte degranulation (GO:0043300) | 3.15866961 |
| 66 | regulation of triglyceride catabolic process (GO:0010896) | 3.15796914 |
| 67 | apoptotic cell clearance (GO:0043277) | 3.13490931 |
| 68 | NIK/NF-kappaB signaling (GO:0038061) | 3.12879325 |
| 69 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.12553777 |
| 70 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.12456753 |
| 71 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.11013643 |
| 72 | barbed-end actin filament capping (GO:0051016) | 3.10893771 |
| 73 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.10128316 |
| 74 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.09161138 |
| 75 | positive regulation of lipid catabolic process (GO:0050996) | 3.08834728 |
| 76 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.06771244 |
| 77 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.06771244 |
| 78 | thymic T cell selection (GO:0045061) | 3.06450124 |
| 79 | bile acid metabolic process (GO:0008206) | 3.05683874 |
| 80 | amino-acid betaine metabolic process (GO:0006577) | 3.03918891 |
| 81 | detection of external biotic stimulus (GO:0098581) | 3.03654709 |
| 82 | regulation of mast cell degranulation (GO:0043304) | 3.02919234 |
| 83 | negative regulation of interleukin-12 production (GO:0032695) | 3.02635120 |
| 84 | macrophage activation involved in immune response (GO:0002281) | 3.00981395 |
| 85 | protein-lipid complex remodeling (GO:0034368) | 2.99044894 |
| 86 | macromolecular complex remodeling (GO:0034367) | 2.99044894 |
| 87 | plasma lipoprotein particle remodeling (GO:0034369) | 2.99044894 |
| 88 | response to laminar fluid shear stress (GO:0034616) | 2.98589412 |
| 89 | pinocytosis (GO:0006907) | 2.96552062 |
| 90 | detection of molecule of bacterial origin (GO:0032490) | 2.93303455 |
| 91 | bile acid and bile salt transport (GO:0015721) | 2.91015702 |
| 92 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.88584648 |
| 93 | cellular extravasation (GO:0045123) | 2.88491973 |
| 94 | complement activation, classical pathway (GO:0006958) | 2.87804174 |
| 95 | regulation of cholesterol esterification (GO:0010872) | 2.87424850 |
| 96 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.86455189 |
| 97 | aromatic amino acid family metabolic process (GO:0009072) | 2.86438249 |
| 98 | complement activation (GO:0006956) | 2.85795167 |
| 99 | cholesterol homeostasis (GO:0042632) | 2.85470550 |
| 100 | sterol homeostasis (GO:0055092) | 2.83094312 |
| 101 | acylglycerol homeostasis (GO:0055090) | 2.80556691 |
| 102 | triglyceride homeostasis (GO:0070328) | 2.80556691 |
| 103 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.80263933 |
| 104 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.79787344 |
| 105 | T cell selection (GO:0045058) | 2.79390770 |
| 106 | lipoprotein metabolic process (GO:0042157) | 2.78673431 |
| 107 | tyrosine metabolic process (GO:0006570) | 2.78651245 |
| 108 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.78498537 |
| 109 | fibrinolysis (GO:0042730) | 2.77897772 |
| 110 | protein-lipid complex subunit organization (GO:0071825) | 2.77604349 |
| 111 | germinal center formation (GO:0002467) | 2.76210360 |
| 112 | glycine metabolic process (GO:0006544) | 2.76054876 |
| 113 | cellular modified amino acid catabolic process (GO:0042219) | 2.75964776 |
| 114 | positive regulation of cholesterol transport (GO:0032376) | 2.75738394 |
| 115 | positive regulation of sterol transport (GO:0032373) | 2.75738394 |
| 116 | immunoglobulin mediated immune response (GO:0016064) | 2.74833051 |
| 117 | positive regulation of B cell differentiation (GO:0045579) | 2.74548016 |
| 118 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.74066125 |
| 119 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.73885534 |
| 120 | positive regulation of hemostasis (GO:1900048) | 2.72548199 |
| 121 | positive regulation of blood coagulation (GO:0030194) | 2.72548199 |
| 122 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.71525485 |
| 123 | plasma lipoprotein particle organization (GO:0071827) | 2.70898331 |
| 124 | acute-phase response (GO:0006953) | 2.68034387 |
| 125 | protein activation cascade (GO:0072376) | 2.68027232 |
| 126 | glycosphingolipid catabolic process (GO:0046479) | 2.67651957 |
| 127 | amino sugar catabolic process (GO:0046348) | 2.67429341 |
| 128 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.66969219 |
| 129 | modulation by symbiont of host cellular process (GO:0044068) | 2.65886782 |
| 130 | glutamate metabolic process (GO:0006536) | 2.64786934 |
| 131 | serine family amino acid metabolic process (GO:0009069) | 2.64611144 |
| 132 | detection of biotic stimulus (GO:0009595) | 2.64495480 |
| 133 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.64337332 |
| 134 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.64213406 |
| 135 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.64213406 |
| 136 | B cell receptor signaling pathway (GO:0050853) | 2.64193719 |
| 137 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.63763398 |
| 138 | negative regulation of granulocyte differentiation (GO:0030853) | 2.63734780 |
| 139 | negative thymic T cell selection (GO:0045060) | 2.61520935 |
| 140 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.61337303 |
| 141 | N-acetylneuraminate metabolic process (GO:0006054) | 2.59854085 |
| 142 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.59577743 |
| 143 | positive T cell selection (GO:0043368) | 2.58221075 |
| 144 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.52917618 |
| 145 | modulation by virus of host process (GO:0019054) | 2.52111968 |
| 146 | embryonic process involved in female pregnancy (GO:0060136) | 2.51982757 |
| 147 | leukocyte aggregation (GO:0070486) | 2.50955140 |
| 148 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.48883347 |
| 149 | regulation of extracellular matrix disassembly (GO:0010715) | 2.47176224 |
| 150 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.46340325 |
| 151 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.43614541 |
| 152 | response to thyroid hormone (GO:0097066) | 2.43110123 |
| 153 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.42715372 |
| 154 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.42575480 |
| 155 | regulation of T cell tolerance induction (GO:0002664) | 2.42068444 |
| 156 | regulation of regulated secretory pathway (GO:1903305) | 2.40790075 |
| 157 | regulation of necroptotic process (GO:0060544) | 2.40768863 |
| 158 | negative T cell selection (GO:0043383) | 2.40498422 |
| 159 | myeloid cell activation involved in immune response (GO:0002275) | 2.37865414 |
| 160 | negative regulation of innate immune response (GO:0045824) | 2.37822469 |
| 161 | glycolipid catabolic process (GO:0019377) | 2.36069420 |
| 162 | histone H3-K36 demethylation (GO:0070544) | 2.35349736 |
| 163 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.35320299 |
| 164 | response to host immune response (GO:0052572) | 2.32941009 |
| 165 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.32941009 |
| 166 | positive regulation of extracellular matrix organization (GO:1903055) | 2.32700094 |
| 167 | myeloid dendritic cell differentiation (GO:0043011) | 2.32439653 |
| 168 | response to host (GO:0075136) | 2.32041205 |
| 169 | response to host defenses (GO:0052200) | 2.32041205 |
| 170 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.32041205 |
| 171 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.31924085 |
| 172 | regulation of tolerance induction (GO:0002643) | 2.31424465 |
| 173 | positive regulation of receptor recycling (GO:0001921) | 2.30602540 |
| 174 | positive regulation of cholesterol efflux (GO:0010875) | 2.30426010 |
| 175 | stress fiber assembly (GO:0043149) | 2.29170017 |
| 176 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.28054288 |
| 177 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.27717276 |
| 178 | regulation of superoxide anion generation (GO:0032928) | 2.26825724 |
| 179 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.25886318 |
| 180 | regulation of macrophage cytokine production (GO:0010935) | 2.24795818 |
| 181 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.24692276 |
| 182 | macrophage activation (GO:0042116) | 2.24632488 |
| 183 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.24408656 |
| 184 | regulation of early endosome to late endosome transport (GO:2000641) | 2.24349575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.22145688 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.58462745 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.20061031 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.71675634 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.25082394 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.93659974 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.93616268 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.70324476 |
| 9 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.61944709 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.55157138 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44831795 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.42126390 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.40367287 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27817594 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.25881921 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.25678530 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25045506 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.22148666 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.21807959 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.16182953 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.15549883 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.12910064 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.11407587 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.03029947 |
| 25 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.98908192 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96398612 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.88094577 |
| 28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.81760718 |
| 29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.78231136 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77246907 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.73751359 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72346760 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71598148 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.71554028 |
| 35 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70718332 |
| 36 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.68832320 |
| 37 | GATA1_19941826_ChIP-Seq_K562_Human | 1.66459786 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65787332 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.62966986 |
| 40 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.62658192 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.60791223 |
| 42 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.60010487 |
| 43 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.57514793 |
| 44 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.57376252 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57367239 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.53102174 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50302368 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.49463480 |
| 49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49285640 |
| 50 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.47643777 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.45640840 |
| 52 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.43378400 |
| 53 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40735510 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.36881254 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34388651 |
| 56 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.33361250 |
| 57 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32537063 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32380614 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30404201 |
| 60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.30327710 |
| 61 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.30141327 |
| 62 | GATA2_19941826_ChIP-Seq_K562_Human | 1.29082922 |
| 63 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28854453 |
| 64 | P68_20966046_ChIP-Seq_HELA_Human | 1.28813162 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27944783 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27746706 |
| 67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27569547 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27506850 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23534845 |
| 70 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22594314 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22049061 |
| 72 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21565875 |
| 73 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20785851 |
| 74 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.19241786 |
| 75 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18989088 |
| 76 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18288770 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17988696 |
| 78 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17675825 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17022466 |
| 80 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.17003833 |
| 81 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.16990624 |
| 82 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.16482414 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16069970 |
| 84 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.15722496 |
| 85 | * MYB_26560356_Chip-Seq_TH1_Human | 1.14975298 |
| 86 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13511414 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10860619 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10209101 |
| 89 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.09484800 |
| 90 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09069673 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08882670 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08284077 |
| 93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08069394 |
| 94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.07935827 |
| 95 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.06285411 |
| 96 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05703847 |
| 97 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04717987 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04522991 |
| 99 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.04377263 |
| 100 | MYB_26560356_Chip-Seq_TH2_Human | 1.04170887 |
| 101 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03181556 |
| 102 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03181085 |
| 103 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02672867 |
| 104 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01170853 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 1.00274999 |
| 106 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.99677616 |
| 107 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99144078 |
| 108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98956882 |
| 109 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.97819248 |
| 110 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97436859 |
| 111 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97417610 |
| 112 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97011232 |
| 113 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.96164902 |
| 114 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95299426 |
| 115 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94717098 |
| 116 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94236674 |
| 117 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.94168119 |
| 118 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.93089936 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.91311709 |
| 120 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90930217 |
| 121 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.90733665 |
| 122 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90271493 |
| 123 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90229616 |
| 124 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90164856 |
| 125 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89896843 |
| 126 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.87939076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.51400189 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.48951590 |
| 3 | MP0009840_abnormal_foam_cell | 3.84148808 |
| 4 | MP0005365_abnormal_bile_salt | 3.54534902 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.34501616 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 3.02148297 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.00525637 |
| 8 | MP0003252_abnormal_bile_duct | 2.97763989 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.65898356 |
| 10 | MP0005083_abnormal_biliary_tract | 2.55747280 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.40501344 |
| 12 | MP0008260_abnormal_autophagy | 2.37518158 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.34237381 |
| 14 | MP0003303_peritoneal_inflammation | 2.29873702 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.16926836 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.12007757 |
| 17 | MP0003172_abnormal_lysosome_physiology | 1.96646377 |
| 18 | MP0003436_decreased_susceptibility_to | 1.94240603 |
| 19 | MP0000609_abnormal_liver_physiology | 1.94086731 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.90117266 |
| 21 | MP0001835_abnormal_antigen_presentation | 1.89359045 |
| 22 | MP0003763_abnormal_thymus_physiology | 1.87989994 |
| 23 | MP0005464_abnormal_platelet_physiology | 1.83080987 |
| 24 | MP0004381_abnormal_hair_follicle | 1.72475949 |
| 25 | MP0006082_CNS_inflammation | 1.68522925 |
| 26 | MP0000569_abnormal_digit_pigmentation | 1.67263573 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.65788425 |
| 28 | MP0001790_abnormal_immune_system | 1.55021278 |
| 29 | MP0005387_immune_system_phenotype | 1.55021278 |
| 30 | MP0000604_amyloidosis | 1.52846334 |
| 31 | MP0002419_abnormal_innate_immunity | 1.52786609 |
| 32 | MP0003828_pulmonary_edema | 1.52770143 |
| 33 | MP0000685_abnormal_immune_system | 1.51586049 |
| 34 | MP0000858_altered_metastatic_potential | 1.51388200 |
| 35 | MP0005332_abnormal_amino_acid | 1.51025939 |
| 36 | MP0001849_ear_inflammation | 1.50336210 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.50108469 |
| 38 | MP0002118_abnormal_lipid_homeostasis | 1.48606242 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.47222553 |
| 40 | MP0004947_skin_inflammation | 1.44505428 |
| 41 | MP0008438_abnormal_cutaneous_collagen | 1.40742440 |
| 42 | MP0001800_abnormal_humoral_immune | 1.38745934 |
| 43 | MP0005409_darkened_coat_color | 1.38637894 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.38470905 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.36311849 |
| 46 | MP0009278_abnormal_bone_marrow | 1.36240521 |
| 47 | MP0005319_abnormal_enzyme/_coenzyme | 1.35589993 |
| 48 | MP0003195_calcinosis | 1.34772813 |
| 49 | MP0002452_abnormal_antigen_presenting | 1.28486015 |
| 50 | MP0008469_abnormal_protein_level | 1.28257793 |
| 51 | MP0005451_abnormal_body_composition | 1.26430110 |
| 52 | MP0002396_abnormal_hematopoietic_system | 1.24974888 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.22175176 |
| 54 | MP0005257_abnormal_intraocular_pressure | 1.21772964 |
| 55 | MP0000598_abnormal_liver_morphology | 1.21396692 |
| 56 | MP0004510_myositis | 1.21146536 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.20685673 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.17540682 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.16855154 |
| 60 | MP0005025_abnormal_response_to | 1.16731238 |
| 61 | MP0000343_altered_response_to | 1.15736267 |
| 62 | MP0002723_abnormal_immune_serum | 1.14958557 |
| 63 | MP0001873_stomach_inflammation | 1.14689784 |
| 64 | MP0004019_abnormal_vitamin_homeostasis | 1.13504653 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.12900981 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.12900981 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.12523865 |
| 68 | MP0005670_abnormal_white_adipose | 1.08901736 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.07512084 |
| 70 | MP0001845_abnormal_inflammatory_respons | 1.05788647 |
| 71 | MP0009764_decreased_sensitivity_to | 1.05738433 |
| 72 | MP0009763_increased_sensitivity_to | 1.04329618 |
| 73 | MP0002928_abnormal_bile_duct | 1.03414874 |
| 74 | MP0001851_eye_inflammation | 1.03038323 |
| 75 | MP0004130_abnormal_muscle_cell | 1.02654285 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 1.01923067 |
| 77 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.01580144 |
| 78 | MP0010307_abnormal_tumor_latency | 1.01073014 |
| 79 | MP0003075_altered_response_to | 1.01061517 |
| 80 | MP0003690_abnormal_glial_cell | 1.00801283 |
| 81 | MP0001853_heart_inflammation | 1.00045973 |
| 82 | MP0000689_abnormal_spleen_morphology | 0.99884341 |
| 83 | MP0005023_abnormal_wound_healing | 0.99841046 |
| 84 | MP0003329_amyloid_beta_deposits | 0.99754195 |
| 85 | MP0001819_abnormal_immune_cell | 0.99493214 |
| 86 | MP0002420_abnormal_adaptive_immunity | 0.98930259 |
| 87 | MP0004858_abnormal_nervous_system | 0.98283751 |
| 88 | MP0005671_abnormal_response_to | 0.97517156 |
| 89 | MP0003183_abnormal_peptide_metabolism | 0.97359525 |
| 90 | MP0003868_abnormal_feces_composition | 0.96997897 |
| 91 | MP0003091_abnormal_cell_migration | 0.96560335 |
| 92 | MP0002933_joint_inflammation | 0.96525857 |
| 93 | MP0002254_reproductive_system_inflammat | 0.96389225 |
| 94 | MP0003448_altered_tumor_morphology | 0.96378545 |
| 95 | MP0002132_abnormal_respiratory_system | 0.95772697 |
| 96 | MP0000703_abnormal_thymus_morphology | 0.95075233 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.90825874 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.90767420 |
| 99 | MP0003866_abnormal_defecation | 0.87314173 |
| 100 | MP0005166_decreased_susceptibility_to | 0.87125026 |
| 101 | MP0000767_abnormal_smooth_muscle | 0.86859926 |
| 102 | MP0000716_abnormal_immune_system | 0.85600046 |
| 103 | MP0002006_tumorigenesis | 0.85355935 |
| 104 | MP0010352_gastrointestinal_tract_polyps | 0.85235465 |
| 105 | MP0002398_abnormal_bone_marrow | 0.85222830 |
| 106 | MP0004883_abnormal_blood_vessel | 0.85080725 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.83379622 |
| 108 | MP0000249_abnormal_blood_vessel | 0.83266732 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.82567786 |
| 110 | MP0009785_altered_susceptibility_to | 0.81957591 |
| 111 | MP0002722_abnormal_immune_system | 0.81746784 |
| 112 | MP0002405_respiratory_system_inflammati | 0.81158010 |
| 113 | MP0005390_skeleton_phenotype | 0.79420130 |
| 114 | MP0003795_abnormal_bone_structure | 0.79304494 |
| 115 | MP0005164_abnormal_response_to | 0.78004677 |
| 116 | MP0001958_emphysema | 0.77872618 |
| 117 | MP0009333_abnormal_splenocyte_physiolog | 0.77272400 |
| 118 | MP0003045_fibrosis | 0.77210139 |
| 119 | MP0002998_abnormal_bone_remodeling | 0.76318483 |
| 120 | MP0003724_increased_susceptibility_to | 0.75611039 |
| 121 | MP0002429_abnormal_blood_cell | 0.74205761 |
| 122 | MP0002877_abnormal_melanocyte_morpholog | 0.73488232 |
| 123 | MP0005310_abnormal_salivary_gland | 0.72856801 |
| 124 | MP0003279_aneurysm | 0.72394637 |
| 125 | MP0001756_abnormal_urination | 0.71891670 |
| 126 | MP0009642_abnormal_blood_homeostasis | 0.70451849 |
| 127 | MP0000371_diluted_coat_color | 0.70151115 |
| 128 | MP0010155_abnormal_intestine_physiology | 0.70083622 |
| 129 | MP0001915_intracranial_hemorrhage | 0.69998379 |
| 130 | MP0002971_abnormal_brown_adipose | 0.69365061 |
| 131 | MP0005334_abnormal_fat_pad | 0.69281674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.75405643 |
| 2 | Complement deficiency (HP:0004431) | 4.41970912 |
| 3 | Xanthomatosis (HP:0000991) | 4.25828655 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 4.02624668 |
| 5 | Myocardial infarction (HP:0001658) | 3.92577650 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.65936563 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.65624045 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 3.55030901 |
| 9 | Abnormality of complement system (HP:0005339) | 3.46127986 |
| 10 | Joint hemorrhage (HP:0005261) | 3.32830782 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 3.30018500 |
| 12 | Glomerulonephritis (HP:0000099) | 3.29576719 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.27055803 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 3.23862145 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 2.93668737 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 2.93618804 |
| 17 | Axonal loss (HP:0003447) | 2.91339022 |
| 18 | Hypercholesterolemia (HP:0003124) | 2.89262903 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 2.84778273 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 2.82814289 |
| 21 | Dysostosis multiplex (HP:0000943) | 2.81239583 |
| 22 | Spontaneous hematomas (HP:0007420) | 2.78465715 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.76166287 |
| 24 | Mitral stenosis (HP:0001718) | 2.75641485 |
| 25 | Hypobetalipoproteinemia (HP:0003563) | 2.75252537 |
| 26 | Cerebral aneurysm (HP:0004944) | 2.71167120 |
| 27 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.70703837 |
| 28 | Mucopolysacchariduria (HP:0008155) | 2.70703837 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 2.69954085 |
| 30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.66448816 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.66448816 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.66448816 |
| 33 | Vertebral compression fractures (HP:0002953) | 2.66057493 |
| 34 | Epidermoid cyst (HP:0200040) | 2.64429323 |
| 35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.64289176 |
| 36 | Gingival bleeding (HP:0000225) | 2.64256813 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.60078521 |
| 38 | Eczematoid dermatitis (HP:0000976) | 2.59402556 |
| 39 | Polycythemia (HP:0001901) | 2.58359320 |
| 40 | Recurrent abscess formation (HP:0002722) | 2.57367490 |
| 41 | Gingivitis (HP:0000230) | 2.55893381 |
| 42 | Hypolipoproteinemia (HP:0010981) | 2.51805681 |
| 43 | Reticulocytosis (HP:0001923) | 2.46500655 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.42748803 |
| 45 | Poikilocytosis (HP:0004447) | 2.42580815 |
| 46 | Nephritis (HP:0000123) | 2.40823312 |
| 47 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.39640817 |
| 48 | Abnormality of glycolipid metabolism (HP:0010969) | 2.39640817 |
| 49 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.39640817 |
| 50 | Mediastinal lymphadenopathy (HP:0100721) | 2.38915526 |
| 51 | Myositis (HP:0100614) | 2.37434427 |
| 52 | Colitis (HP:0002583) | 2.37351417 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.37284880 |
| 54 | Amyloidosis (HP:0011034) | 2.33148523 |
| 55 | Increased IgE level (HP:0003212) | 2.33080750 |
| 56 | Recurrent fungal infections (HP:0002841) | 2.30989735 |
| 57 | Osteolytic defects of the hand bones (HP:0009699) | 2.30043373 |
| 58 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.30043373 |
| 59 | Peritonitis (HP:0002586) | 2.30039263 |
| 60 | Broad face (HP:0000283) | 2.29813820 |
| 61 | Purpura (HP:0000979) | 2.29109769 |
| 62 | Increased connective tissue (HP:0009025) | 2.26721309 |
| 63 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.25093552 |
| 64 | Chronic obstructive pulmonary disease (HP:0006510) | 2.24122718 |
| 65 | Obstructive lung disease (HP:0006536) | 2.24122718 |
| 66 | Pustule (HP:0200039) | 2.24031895 |
| 67 | Acanthocytosis (HP:0001927) | 2.23966280 |
| 68 | Abnormality of the intrinsic pathway (HP:0010989) | 2.23308762 |
| 69 | Hyperammonemia (HP:0001987) | 2.23258819 |
| 70 | Thin bony cortex (HP:0002753) | 2.21961621 |
| 71 | Hepatocellular carcinoma (HP:0001402) | 2.20219226 |
| 72 | Hemorrhage of the eye (HP:0011885) | 2.19057605 |
| 73 | Obstructive sleep apnea (HP:0002870) | 2.17625289 |
| 74 | Menorrhagia (HP:0000132) | 2.14549608 |
| 75 | Hyperglycinemia (HP:0002154) | 2.13876919 |
| 76 | Impaired platelet aggregation (HP:0003540) | 2.13693658 |
| 77 | Abnormal platelet function (HP:0011869) | 2.13693658 |
| 78 | Esophageal varix (HP:0002040) | 2.13539169 |
| 79 | Skin nodule (HP:0200036) | 2.12842136 |
| 80 | Meningitis (HP:0001287) | 2.11024604 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 2.11010749 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 2.08731070 |
| 83 | Ketosis (HP:0001946) | 2.08482835 |
| 84 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.06839737 |
| 85 | Recurrent cutaneous fungal infections (HP:0011370) | 2.06839737 |
| 86 | Protrusio acetabuli (HP:0003179) | 2.04080622 |
| 87 | Increased serum ferritin (HP:0003281) | 2.03105297 |
| 88 | Hyperglycinuria (HP:0003108) | 2.02917103 |
| 89 | Epistaxis (HP:0000421) | 2.02347054 |
| 90 | Orchitis (HP:0100796) | 2.00998359 |
| 91 | Abnormality of macrophages (HP:0004311) | 2.00428863 |
| 92 | Fat malabsorption (HP:0002630) | 1.99706033 |
| 93 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99695496 |
| 94 | Abnormality of purine metabolism (HP:0004352) | 1.99472201 |
| 95 | Osteomyelitis (HP:0002754) | 1.99265806 |
| 96 | Prolonged bleeding time (HP:0003010) | 1.99061186 |
| 97 | Upper motor neuron abnormality (HP:0002127) | 1.98982708 |
| 98 | Hematochezia (HP:0002573) | 1.97590521 |
| 99 | Abnormality of the fingertips (HP:0001211) | 1.97455804 |
| 100 | Peripheral demyelination (HP:0011096) | 1.96634261 |
| 101 | Recurrent skin infections (HP:0001581) | 1.96227807 |
| 102 | Spondylolisthesis (HP:0003302) | 1.96039508 |
| 103 | Abnormality of glycine metabolism (HP:0010895) | 1.95243787 |
| 104 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.95243787 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93119593 |
| 106 | Asymmetric septal hypertrophy (HP:0001670) | 1.93011179 |
| 107 | Spastic diplegia (HP:0001264) | 1.92709999 |
| 108 | Distal lower limb amyotrophy (HP:0008944) | 1.92592949 |
| 109 | Abnormality of nucleobase metabolism (HP:0010932) | 1.92534743 |
| 110 | Interstitial pulmonary disease (HP:0006530) | 1.92477120 |
| 111 | Cervical subluxation (HP:0003308) | 1.91420960 |
| 112 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91319252 |
| 113 | Neurofibrillary tangles (HP:0002185) | 1.91192517 |
| 114 | Loss of speech (HP:0002371) | 1.90924519 |
| 115 | Polygenic inheritance (HP:0010982) | 1.90419129 |
| 116 | Mitral valve prolapse (HP:0001634) | 1.89084666 |
| 117 | Periodontitis (HP:0000704) | 1.88436757 |
| 118 | Hypochromic microcytic anemia (HP:0004840) | 1.88194291 |
| 119 | Malnutrition (HP:0004395) | 1.88016376 |
| 120 | Distal lower limb muscle weakness (HP:0009053) | 1.88012149 |
| 121 | Abnormality of the nasal mucosa (HP:0000433) | 1.87864600 |
| 122 | Cholelithiasis (HP:0001081) | 1.87705702 |
| 123 | Hyperacusis (HP:0010780) | 1.87412808 |
| 124 | Hyperbilirubinemia (HP:0002904) | 1.87148246 |
| 125 | Abnormal platelet volume (HP:0011876) | 1.87025040 |
| 126 | Cerebral inclusion bodies (HP:0100314) | 1.86652647 |
| 127 | Cellulitis (HP:0100658) | 1.85488052 |
| 128 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.85448518 |
| 129 | Pathologic fracture (HP:0002756) | 1.84626677 |
| 130 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.84522453 |
| 131 | Increased mean platelet volume (HP:0011877) | 1.84252856 |
| 132 | Hypertriglyceridemia (HP:0002155) | 1.84240259 |
| 133 | Emphysema (HP:0002097) | 1.84192371 |
| 134 | Recurrent viral infections (HP:0004429) | 1.84090330 |
| 135 | Inflammation of the large intestine (HP:0002037) | 1.83803826 |
| 136 | Neuronal loss in central nervous system (HP:0002529) | 1.82861885 |
| 137 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.82575202 |
| 138 | Aneurysm (HP:0002617) | 1.82536528 |
| 139 | Abnormality of proline metabolism (HP:0010907) | 1.81861174 |
| 140 | Hydroxyprolinuria (HP:0003080) | 1.81861174 |
| 141 | Hypoglycemic coma (HP:0001325) | 1.79966751 |
| 142 | Premature rupture of membranes (HP:0001788) | 1.79799271 |
| 143 | Increased variability in muscle fiber diameter (HP:0003557) | 1.79729538 |
| 144 | Bone pain (HP:0002653) | 1.78987376 |
| 145 | Dilatation of the ascending aorta (HP:0005111) | 1.77002113 |
| 146 | J-shaped sella turcica (HP:0002680) | 1.75433396 |
| 147 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.75258165 |
| 148 | Restrictive lung disease (HP:0002091) | 1.74648524 |
| 149 | Joint stiffness (HP:0001387) | 1.74347040 |
| 150 | Vasculitis (HP:0002633) | 1.74275415 |
| 151 | Gastrointestinal stroma tumor (HP:0100723) | 1.72124421 |
| 152 | Slow saccadic eye movements (HP:0000514) | 1.69026291 |
| 153 | Petechiae (HP:0000967) | 1.68881314 |
| 154 | Ocular albinism (HP:0001107) | 1.68463280 |
| 155 | Urticaria (HP:0001025) | 1.67392590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.02579712 |
| 2 | PRPF4B | 3.85489038 |
| 3 | ERN1 | 3.75122835 |
| 4 | PKN2 | 2.96804010 |
| 5 | TAOK3 | 2.94853963 |
| 6 | MAP4K1 | 2.55928761 |
| 7 | SIK1 | 2.50451795 |
| 8 | SMG1 | 2.46511472 |
| 9 | MAP3K10 | 2.41782617 |
| 10 | TYK2 | 2.36722728 |
| 11 | CAMK1D | 2.18688854 |
| 12 | TGFBR2 | 2.15819889 |
| 13 | PTK6 | 2.12670668 |
| 14 | FGFR4 | 2.09129598 |
| 15 | TBK1 | 2.08417429 |
| 16 | CDK12 | 1.94057875 |
| 17 | CSF1R | 1.89797404 |
| 18 | EEF2K | 1.80037467 |
| 19 | JAK1 | 1.77583737 |
| 20 | EPHB1 | 1.75983705 |
| 21 | CAMK1G | 1.60844674 |
| 22 | BLK | 1.58659985 |
| 23 | TTN | 1.57942631 |
| 24 | MAP3K11 | 1.54601191 |
| 25 | RIPK4 | 1.53452118 |
| 26 | TAOK2 | 1.49310083 |
| 27 | MAP2K3 | 1.44652934 |
| 28 | STK10 | 1.41189314 |
| 29 | GRK6 | 1.37886902 |
| 30 | CDC42BPA | 1.37598383 |
| 31 | MAP3K14 | 1.36970948 |
| 32 | SIK2 | 1.34869388 |
| 33 | KIT | 1.34564248 |
| 34 | IRAK3 | 1.33863849 |
| 35 | JAK3 | 1.32445238 |
| 36 | JAK2 | 1.31325642 |
| 37 | MARK2 | 1.29714862 |
| 38 | PRKD2 | 1.28110747 |
| 39 | ZAP70 | 1.27208407 |
| 40 | NME2 | 1.25971435 |
| 41 | MAP3K1 | 1.25937736 |
| 42 | BCKDK | 1.24351632 |
| 43 | TNK2 | 1.22812004 |
| 44 | CSK | 1.20055552 |
| 45 | ICK | 1.19616741 |
| 46 | RIPK1 | 1.19077028 |
| 47 | IKBKB | 1.13627909 |
| 48 | HCK | 1.07510724 |
| 49 | CDK6 | 1.06734580 |
| 50 | MAPK11 | 1.05511200 |
| 51 | MAP3K13 | 1.03148961 |
| 52 | BMX | 1.01927676 |
| 53 | SCYL2 | 0.99925152 |
| 54 | LRRK2 | 0.98717572 |
| 55 | TAOK1 | 0.98064080 |
| 56 | MTOR | 0.94427046 |
| 57 | HIPK2 | 0.92711293 |
| 58 | RPS6KA2 | 0.89236838 |
| 59 | CHUK | 0.89223592 |
| 60 | RPS6KA4 | 0.88127373 |
| 61 | PDGFRA | 0.86573439 |
| 62 | SYK | 0.86350177 |
| 63 | CDK4 | 0.84791223 |
| 64 | STK3 | 0.83642875 |
| 65 | IKBKE | 0.83508745 |
| 66 | MAP3K7 | 0.83214597 |
| 67 | SIK3 | 0.82277261 |
| 68 | MAP3K6 | 0.82029896 |
| 69 | PAK4 | 0.80920843 |
| 70 | RPS6KC1 | 0.80741529 |
| 71 | RPS6KL1 | 0.80741529 |
| 72 | FLT3 | 0.79630574 |
| 73 | PTK2 | 0.75362826 |
| 74 | PDPK1 | 0.73486323 |
| 75 | DDR2 | 0.73383935 |
| 76 | ITK | 0.73300251 |
| 77 | PDGFRB | 0.73021844 |
| 78 | STK4 | 0.72158417 |
| 79 | MAPK7 | 0.71300331 |
| 80 | MAP3K3 | 0.70837087 |
| 81 | PIM1 | 0.69408635 |
| 82 | BTK | 0.68379236 |
| 83 | IRAK4 | 0.68053015 |
| 84 | MAP3K8 | 0.66582422 |
| 85 | NEK9 | 0.64965751 |
| 86 | LATS1 | 0.64696974 |
| 87 | ABL2 | 0.62528529 |
| 88 | TESK2 | 0.61509742 |
| 89 | LCK | 0.61285290 |
| 90 | KSR2 | 0.60938177 |
| 91 | PDK1 | 0.60852932 |
| 92 | PRKAA2 | 0.60161812 |
| 93 | IRAK2 | 0.59813189 |
| 94 | RPS6KA6 | 0.59610000 |
| 95 | FGR | 0.59430877 |
| 96 | MST1R | 0.58118999 |
| 97 | SGK3 | 0.57486074 |
| 98 | FES | 0.57361372 |
| 99 | RET | 0.57109595 |
| 100 | MARK3 | 0.56963213 |
| 101 | EGFR | 0.56908637 |
| 102 | LYN | 0.56248164 |
| 103 | NEK2 | 0.55610147 |
| 104 | MAP3K9 | 0.54895113 |
| 105 | DYRK1B | 0.53818169 |
| 106 | PAK2 | 0.53769379 |
| 107 | PRKCH | 0.53587134 |
| 108 | DAPK2 | 0.53349828 |
| 109 | ALK | 0.52149369 |
| 110 | ABL1 | 0.49815679 |
| 111 | MAPK12 | 0.48070613 |
| 112 | PRKAA1 | 0.47585258 |
| 113 | FGFR3 | 0.46795721 |
| 114 | MAP2K2 | 0.46336717 |
| 115 | CAMKK1 | 0.44858326 |
| 116 | MATK | 0.41868770 |
| 117 | MELK | 0.39313730 |
| 118 | MAP3K2 | 0.38894376 |
| 119 | MAPKAPK2 | 0.37828005 |
| 120 | PRKD3 | 0.37557746 |
| 121 | TESK1 | 0.36666972 |
| 122 | INSRR | 0.35761729 |
| 123 | CAMK4 | 0.35532423 |
| 124 | GSK3A | 0.34054254 |
| 125 | TRPM7 | 0.33064183 |
| 126 | PRKD1 | 0.32351374 |
| 127 | INSR | 0.30627372 |
| 128 | STK11 | 0.30319503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.37088967 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.30184779 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.17287685 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.09457420 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.76844963 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.68549592 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48788947 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.14930414 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.00533115 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.91230916 |
| 11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.85149777 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.84329500 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.83030051 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.70370133 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.65673668 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.62931295 |
| 17 | ABC transporters_Homo sapiens_hsa02010 | 1.53047790 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.51020542 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.47421138 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.40737337 |
| 21 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.35488648 |
| 22 | Lysine degradation_Homo sapiens_hsa00310 | 1.34451833 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.32488575 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32125620 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.31641492 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.31294828 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.28307286 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25490077 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.25320772 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.24986476 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.23359766 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.23165693 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.21838470 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20914575 |
| 35 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.19531146 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.14093368 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13629574 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12909447 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11213905 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.10884251 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.09615737 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08852277 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.08804290 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 1.08338249 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.07462668 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.07144568 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06883662 |
| 48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.05056528 |
| 49 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.00220856 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98997156 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98937106 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98473660 |
| 53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98438726 |
| 54 | Endometrial cancer_Homo sapiens_hsa05213 | 0.98396411 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.96653142 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96226422 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94628848 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92755421 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92414441 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.91182253 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.91142597 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91089218 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.90777977 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.89562434 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88933392 |
| 66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.87700410 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86846993 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85288340 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84630305 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83599132 |
| 71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83512154 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82561567 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.82220274 |
| 74 | Asthma_Homo sapiens_hsa05310 | 0.80760952 |
| 75 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.80435449 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79644879 |
| 77 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.79571427 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79348241 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.78446085 |
| 80 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78211899 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.74650250 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74458115 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74448626 |
| 84 | Tuberculosis_Homo sapiens_hsa05152 | 0.73534667 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.72752891 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72417717 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.71721060 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70799473 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70590561 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70443034 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.70279945 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69917397 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.69900961 |
| 94 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.69468989 |
| 95 | Prostate cancer_Homo sapiens_hsa05215 | 0.69394065 |
| 96 | Malaria_Homo sapiens_hsa05144 | 0.68802688 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67893917 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67837649 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67833622 |
| 100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67378130 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66452017 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66395828 |
| 103 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65903062 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65756631 |
| 105 | Focal adhesion_Homo sapiens_hsa04510 | 0.65056409 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64781097 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.64661397 |
| 108 | Shigellosis_Homo sapiens_hsa05131 | 0.64373132 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.63299111 |
| 110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62976907 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62408741 |
| 112 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61360788 |
| 113 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61181287 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59718589 |
| 115 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59088498 |
| 116 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58831404 |
| 117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58050022 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57504002 |
| 119 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.56821439 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55996132 |
| 121 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55958670 |
| 122 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55565944 |
| 123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55479622 |
| 124 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55094020 |
| 125 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54981535 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53493392 |
| 127 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.52885218 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.52697951 |
| 129 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52573925 |
| 130 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52065387 |
| 131 | Measles_Homo sapiens_hsa05162 | 0.50679138 |
| 132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50639998 |
| 133 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49384710 |
| 134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47233400 |
| 135 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45294888 |
| 136 | Influenza A_Homo sapiens_hsa05164 | 0.43496898 |
| 137 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41410095 |
| 138 | Hepatitis C_Homo sapiens_hsa05160 | 0.40721551 |
| 139 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40227300 |
| 140 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40080043 |
| 141 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39230355 |
| 142 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38129758 |
| 143 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37296633 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37247710 |
| 145 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36400905 |
| 146 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35426171 |
| 147 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34889480 |
| 148 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.34856610 |
| 149 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.33988081 |
| 150 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.33725946 |
| 151 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33192000 |
| 152 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.32122953 |
| 153 | Hepatitis B_Homo sapiens_hsa05161 | 0.31557716 |

